Review Article | Volume : 1 Issue : 2, April 2011

Per oral extended release products -An overview

B.Jayanthi,  P.K.Manna,  S.Madhusudhan,  G.P.Mohanta,  R.Manavalan   
B.Jayanthi, P.K.Manna, S.Madhusudhan, G.P.Mohanta, R.Manavalan

Department of Pharmacy Annamalai University Annamalai Nagar, India.

Open Access   

PDF [ 0.3 MB]
Request Permission
Share
Download Citation
Print
Download PDF
Abstract

The use of extended-release products offers some potential advantages in patient convenience, compliance and therapeutic outcomes. However, the range of drugs for which clinically significant advantages have been shown is limited. Prescribers and pharmacists should be aware of these products and have knowledge of their clinical use in selected patient groups. In some instances, the formulation is probably serving a marketing objective rather than a clinical objective.


Keyword:     Extended-release Formulation Marketed product Clinical significant.

Copyright:The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
HTML Full Text

Reference

Article Metrics
464 Views 41 Downloads 505 Total

Year

Month

Related Search

By author names